By Dr. Matt Gianforte, D.C. | Functional Medicine Clinician
A fasting glucose that creeps up a few points each year, an afternoon crash after lunch and a waistline that keeps growing often point to the same hidden problem. Insulin resistance can build for years before a lab report flags it, which is why many adults look for a natural way to support their blood sugar. Berberine for insulin resistance has drawn growing interest, and the research behind it is worth a close look.
Berberine is a bitter yellow compound found in plants such as goldenseal and Chinese goldthread. Randomized trials suggest it can lower fasting glucose, A1C and HOMA-IR, a calculated marker of insulin resistance, when taken with meals for one to three months. Most of those trials were small and many were run in China, so berberine fits best as one part of a plan that also covers food, movement, sleep and a medication review.
- Pooled trials link berberine with lower fasting glucose and A1C, and several trials also report lower fasting insulin and HOMA-IR.
- Reviewers rate much of this research as low quality, because the trials were small, short and mostly done in Chinese patients.
- Stomach upset and constipation are the most common berberine side effects, and berberine can change how the liver clears several prescription drugs.
- People who are pregnant, breastfeeding or taking diabetes medication need a clinician's guidance before starting berberine.
Why Insulin Resistance Is Easy to Miss
Before looking at the research, it helps to see why insulin resistance so often goes unnoticed. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) describes it as a condition in which the body doesn't respond to insulin the way it should. Over time, the pancreas may not make enough insulin to move the extra glucose into cells, and blood sugar starts to rise.
The early years are quiet because the pancreas keeps up by making more insulin. NIDDK data show that about 97.6 million American adults had prediabetes in 2021, defined as a fasting glucose of 100 to 125 mg/dL or an A1C of 5.7% to 6.4%.
Because fasting glucose is a late signal, researchers developed HOMA-IR, short for homeostasis model assessment of insulin resistance. It uses fasting glucose and fasting insulin together to estimate how hard the body works to keep glucose steady (Matthews et al., 1985). Its estimates tracked closely with the clamp test, a detailed research measure of insulin sensitivity, and several berberine trials report it next to fasting glucose and A1C.
What the Research Says About Berberine for Insulin Resistance
With those markers in mind, the clinical research becomes easier to follow. Interest in berberine for blood sugar began in 1988, when a glucose-lowering effect was first reported while it was being used for diarrhea in patients with diabetes (Dong et al., 2012).
An early pilot gave 36 adults with new type 2 diabetes either berberine or metformin at 500 mg three times a day for 3 months, and the drop in blood sugar was similar in both groups (Yin et al., 2008). In a second arm of that research, 48 adults with poorly controlled diabetes added berberine, and their fasting insulin fell by 28.1% while HOMA-IR fell by 44.7%. That arm had no control group, so it shows a change over time rather than proof that berberine caused it.
A placebo-controlled trial followed 116 people with type 2 diabetes and high cholesterol who took 1 gram of berberine a day for 3 months (Zhang et al., 2008). Research data showed A1C dropping from 7.5% to 6.6%, along with lower triglycerides and LDL cholesterol than placebo. Insulin sensitivity on the clamp test improved within the berberine group, yet the difference from placebo was not statistically significant.
Research outside China points the same way. In Mexico, 24 adults with metabolic syndrome took 500 mg of berberine or a placebo three times a day before meals for 3 months (Pérez-Rubio et al., 2013). The berberine group released less total insulin after a glucose drink, and their Matsuda index, another insulin sensitivity score, rose from 2.1 to 3.1.
Pooled reviews give the wider picture. Across 28 randomized trials with 2,313 people, berberine was linked to lower fasting glucose, after-meal glucose and A1C than control groups, although the effect faded past 90 days of use, above 2 grams a day and over age 60 (Liang et al., 2019). A newer review of 50 trials found that berberine added to diabetes medication improved fasting insulin and HOMA-IR, with 0.9 to 1.5 grams a day as the most common dose (Wang et al., 2024).
| Research | Who took part | Dose and length | Main finding |
|---|---|---|---|
| Yin et al., 2008 | 36 adults with new type 2 diabetes | 500 mg three times a day, 3 months | Blood sugar effect similar to metformin. |
| Zhang et al., 2008 | 116 adults with type 2 diabetes and high cholesterol | 1 gram a day, 3 months | Lower A1C, triglycerides and LDL than placebo. |
| Pérez-Rubio et al., 2013 | 24 adults with metabolic syndrome | 500 mg three times a day, 3 months | Less insulin released and better insulin sensitivity. |
| Wang et al., 2024 | 50 trials in type 2 diabetes | Most often 0.9 to 1.5 grams a day | With medication, better fasting insulin and HOMA-IR. |
These results come with real limits that deserve equal weight. Reviewers judged the berberine trials to be generally low in quality, with small samples and unclear risks of bias, and every trial in that review was run in Chinese patients (Dong et al., 2012). A second pooled review of 27 trials also searched Chinese-language databases and said the benefit can be confirmed only to a limited degree (Lan et al., 2015).
The research supports berberine as a promising helper for fasting glucose, A1C and HOMA-IR, while larger and better-designed trials in more diverse groups are still needed.
Root Cause: How Berberine Works on Insulin Resistance
The trial results make more sense inside the cell. Insulin normally acts like a key that tells muscle, liver and fat cells to open their doors and pull glucose out of the blood. In insulin resistance, the lock gets sticky, so the pancreas sends more keys to get the same job done. This guide to insulin resistance and inflammation explains one reason the lock gets sticky.
Berberine appears to work partly through a side door. In animal and cell research, it switched on AMP-activated protein kinase (AMPK), an enzyme that senses when a cell is low on energy and tells it to burn more fuel (Lee et al., 2006). It also moved GLUT4, the transporter that carries glucose into muscle cells, to the cell surface through a path that did not depend on the usual insulin signal.
These findings come from rodents and cells, so they explain a likely mechanism rather than prove what happens in every person. Absorption matters too, because very little berberine may be absorbed when people take goldenseal by mouth, according to the National Center for Complementary and Integrative Health (NCCIH). The trials also split the daily dose across meals, and that detail shapes how a protocol is built.
A Functional Medicine Protocol for Berberine and Insulin Resistance
Since berberine works best within a larger plan, functional medicine practitioners typically build the protocol around testing, daily basics and a defined trial period. The steps below follow the doses and time frames used in the research.
- Check fasting glucose, A1C and fasting insulin first, so HOMA-IR can be calculated and compared later.
- Review every prescription and supplement with a clinician, since berberine can change how the liver clears several medications.
- Put the foundations in place, including regular movement, fiber-rich meals and enough sleep.
- Take berberine with meals and split the dose, because stomach upset is the most common complaint.
- Stay near the studied range of 0.9 to 1.5 grams a day, the doses used most often in the research (Wang et al., 2024).
- Recheck labs after about 3 months, since most trials ran 1 to 3 months and the effect looked weaker past 90 days (Liang et al., 2019).
The recheck shows whether berberine is earning its place. If the numbers have not moved, the plan should shift toward other drivers such as sleep, stress or nutrient status. This overview of insulin resistance vitamins covers the nutrients often checked alongside these labs.
Supplement Support for Insulin Resistance
Once labs and habits are in place, supplements can support the plan, and three options fit the research covered here.
Plain berberine is the form tested in the trials covered above. Berberine by XYMOGEN provides 1,000 mg of berberine HCl per serving, and its directions say to take it as a healthcare provider directs, typically 500 mg twice daily with meals. Shop Berberine →
MedCaps IS by XYMOGEN combines chromium, berberine, alpha lipoic acid and B vitamins, with a label dose of 2 capsules daily with meals. Chromium might help insulin work, although the NIH Office of Dietary Supplements notes conflicting trial results and possible benefit mainly in people with more severe insulin resistance. Because this formula already contains berberine, it should not be stacked on a separate berberine product without a clinician's input. Shop MedCaps IS →
Alpha lipoic acid (ALA) is an antioxidant that supports the mitochondria, the parts of the cell that turn glucose into energy. Across 24 randomized trials in people with metabolic diseases, ALA lowered fasting glucose, A1C and HOMA-IR (Akbari et al., 2018). ALAmax CR by XYMOGEN uses the R form of ALA in a controlled-release tablet, with a label dose of 1 to 2 tablets daily. Shop ALAmax CR →
A clinician can match these options to each person's labs and tolerance. Explore practitioner-grade supplement protocols at drmattgianforte.com.
Lifestyle Integration for Insulin Resistance
Daily habits shape insulin resistance more than any supplement can. In the Diabetes Prevention Program research described by NIDDK, people who lost 5% to 7% of their starting weight lowered their chance of developing type 2 diabetes. Meals built on vegetables, legumes and whole grains also suit berberine, which is taken with food.
Movement is a direct lever, because working muscles pull glucose from the blood. Walking after meals and strength work are easy starting points, and this guide to metabolic flexibility explains how the body learns to switch between burning glucose and fat. NIDDK also lists getting enough sleep among the healthy habits that matter. Even with these habits in place, some situations call for a clinician before berberine is started.
Berberine Side Effects and When to See a Clinician
Berberine side effects are usually mild but common. In the Yin pilot research, 34.5% of patients had short-lived stomach and bowel effects (Yin et al., 2008). Constipation was one of the most common complaints and eased after the dose was lowered, while no severe low blood sugar was found in the included trials (Dong et al., 2012).
Drug interactions are the bigger concern. In healthy men, 2 weeks of berberine at 300 mg three times a day lowered the activity of three liver enzymes, CYP2D6, CYP2C9 and CYP3A4, which clear many common drugs (Guo et al., 2012). NCCIH also reports that metformin levels fell about 25 percent in healthy adults given goldenseal extract plus metformin, enough to potentially hinder glucose control. Don't stop or change prescribed medication without talking to your clinician.
Checking a few situations first keeps the protocol safe, and these call for a clinician's guidance before berberine is started:
- Pregnancy or breastfeeding, because NCCIH warns that berberine can be harmful to newborns.
- Any diabetes medication, including metformin or insulin, since berberine adds its own glucose-lowering effect.
- Other prescriptions cleared through the CYP2D6, CYP2C9 or CYP3A4 liver enzymes.
Conclusion: What the Research Means for Berberine
Insulin resistance builds quietly, but its markers can be measured and followed over time. The research on berberine for insulin resistance shows improvements in these markers across many small trials, with honest limits on trial quality and on how long the effect lasts. Used with meals and a medication review, it can be a reasonable part of a root-cause plan. This guide to the functional blood sugar solution covers the broader foundation.
Practitioner-grade protocols for insulin resistance are available at drmattgianforte.com, formulated with the same clinical-quality supplements used in functional medicine practice. Explore the Protocol →
FAQ
Does berberine actually work for insulin resistance?
Pooled trials link berberine with lower fasting glucose and A1C, and some trials also show lower fasting insulin and HOMA-IR, which suggests it may support insulin sensitivity. Most trials were small, so results vary from person to person.
What is the best berberine dosage for insulin resistance?
The most common berberine dosage in the research is 0.9 to 1.5 grams a day, split across meals. In pooled data, the effect looked weaker at doses above 2 grams a day.
What are the side effects of berberine?
The most common berberine side effects are stomach upset, constipation and other short-lived bowel changes. In the trials, constipation eased after the dose was lowered.
Is berberine safe to take with metformin?
Berberine and metformin both lower blood sugar, and berberine can change how the liver clears several medications. Anyone taking metformin or other diabetes medication should talk with their clinician before adding berberine.
How long does berberine take to lower blood sugar?
In one pilot, fasting and after-meal glucose dropped within the first week, and most trials measured results at 1 to 3 months. A lab recheck at about 3 months shows whether it is working.
Can you take berberine while pregnant or breastfeeding?
No, NCCIH advises against goldenseal during pregnancy and breastfeeding because its berberine can be harmful to newborns. A clinician can suggest safer options.
References
- Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008. PubMed 18442638
- Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008. PubMed 18397984
- Pérez-Rubio KG, González-Ortiz M, Martínez-Abundis E, Robles-Cervantes JA, Espinel-Bermúdez MC. Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab Syndr Relat Disord. 2013. PubMed 23808999
- Dong H, Wang N, Zhao L, Lu F. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med. 2012. PubMed 23118793
- Lan J, Zhao Y, Dong F, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. 2015. PubMed 25498346
- Liang Y, Xu X, Yin M, et al. Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis. Endocr J. 2019. PubMed 30393248
- Wang J, Bi C, Xi H, Wei F. Effects of administering berberine alone or in combination on type 2 diabetes mellitus: a systematic review and meta-analysis. Front Pharmacol. 2024. PubMed 39640489
- Lee YS, Kim WS, Kim KH, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006. PubMed 16873688
- Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012. PubMed 21870106
- Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985. PubMed 3899825
- Akbari M, Ostadmohammadi V, Lankarani KB, et al. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Metabolism. 2018. PubMed 29990473
- National Institute of Diabetes and Digestive and Kidney Diseases. Insulin Resistance & Prediabetes. niddk.nih.gov
- National Center for Complementary and Integrative Health. Goldenseal. nccih.nih.gov
- NIH Office of Dietary Supplements. Chromium: Fact Sheet for Health Professionals. ods.od.nih.gov
This article is for education and isn't medical advice. Readers should talk with their own healthcare provider about their situation.
These statements have not been evaluated by the Food and Drug Administration. Products and information on this site are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement.
